Covid-2019 - 2023-01-01
Once-favored Covid drugs ineffective on Omicron may be putting millions at risk
West’s attempts to deny China’s three-year effort against COVID by criticizing a short period of imperfection will end up in vain
China’s Xi Jinping Provides Rare Acknowledgment of Covid-19 Policies’ Toll
Covid-2019 - 2022-12-31
Highly immune evasive omicron XBB.1.5 variant is quickly becoming dominant in U.S. as it doubles weekly
Covid Is China’s Price for Rejoining Humanity
Medicare Keeps Spending More on COVID-19 Testing. Fraud and Overspending Are Partly Why.
Recession? No Thanks, We’ve Already Had One
Our reflections on a complex and difficult 2022. We had our wins, we had our misses.